Enhance Skin Products Inc. (fka EHSK)

[JDoggs_Money]

In relation to my stickied DD...

It looks like we have a reverse merger by way of Biosurface Ltd purchasing the assets of EHSK. How this plays out will be interesting...

If you notice, Biosurface Ltd is a private UK company that wants to purchase the assets of $EHSK for a swap of the private company's shares. The stickied DD shows that Biosurface is run by some very good people growing other private pharma businesses exponentially in Europe. I believe this to be a triangular reverse merger...Essentially Venn Life Sciences and/or Innovenn has created Biosurface Ltd to be the buffer to acquire a US public company (EHSK).

The question is what will we see out of it? Either EHSK buys us out at almost .04/share, we receive private shares of Biosurface in exchange for our shares (which would probably be worth more than .04 quickly), or EHSK continues as a business separately, but now has $3.5 mil cash in pocket after liabilities are paid off and major shareholder equity to move forward?

Either way, this is WAY undervalued still...

http://www.reverse-merger.com/mergers-and-acquisitions-types-of-transactions/

"From a legal structure perspective, an M&A transaction can be an asset purchase, a stock purchase, a forward merger or a forward or reverse triangular merger. In an asset purchase, stock acquisition, forward merger or forward triangular merger, the acquiring company remains in control. In a reverse merger or a reverse triangular merger, the target company shareholders and management gain control of the acquiring company.

In an asset purchase transaction, the acquirer can pick and choose the assets that it is purchasing, and likewise the liabilities it is assuming. An asset purchase can be complex and requires careful drafting to ensure that the desired assets are included, including all tangible and intangible rights thereto, and that only the specified liabilities are legally assumed. Third-party consents are often required to achieve the result."